Skip to content
2000
Volume 9, Issue 4
  • ISSN: 1389-5575
  • E-ISSN: 1875-5607

Abstract

We described chemical inhibitors of Mos1 transposition. Some were already known to affect a related prokaryotic transposase (Tn5) or HIV-1 integrase, whereas the other were new compounds in this field. The new compounds were all organized around a bis-(heteroaryl)maleimides scaffold. Their mechanism of action depended on the chemical substitutions on the scaffold. The cross-activity, between HIV-1 integrase and Mos1 transposase, of the new group of inhibitors showed that Mos1 transposase could constitute an excellent surrogate HIV-1 inhibitor screen.

Loading

Article metrics loading...

/content/journals/mrmc/10.2174/138955709787847912
2009-04-01
2025-10-14
Loading full text...

Full text loading...

/content/journals/mrmc/10.2174/138955709787847912
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test